MTCH
50
6
DOW
27
-3
KR
53
-2
EL
37
-5
WAT
49
-6
C
78
-3
HST
47
-2
UHS
66
-4
ES
32
-7
LH
42
-7
NEM
48
-4
MUR
39
-4
AKAM
37
-3
EOG
47
-3
PPG
50
-4
MS
81
2
EA
50
-2
HBAN
85
-3
LOW
56
-2
DD
37
-7
MTCH
50
6
DOW
27
-3
KR
53
-2
EL
37
-5
WAT
49
-6
C
78
-3
HST
47
-2
UHS
66
-4
ES
32
-7
LH
42
-7
NEM
48
-4
MUR
39
-4
AKAM
37
-3
EOG
47
-3
PPG
50
-4
MS
81
2
EA
50
-2
HBAN
85
-3
LOW
56
-2
DD
37
-7
Financhill
Back

Innate Pharma SA Vs. Simulations Plus Industry Stock Comparison

Sell
40

IPHA
Innate Pharma SA

Last Price:
$2.11
Seasonality Move:
-9.96%
Sell
36

SLP
Simulations Plus

Last Price:
$30.74
Seasonality Move:
3.81%
Sell
40
Innate Pharma SA (IPHA) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

  • The current Innate Pharma SA [IPHA] share price is $2.08. The Score for IPHA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • IPHA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Simulations Plus (SLP) is a Sell

Is Simulations Plus a Buy, Sell or Hold?

  • The current Simulations Plus [SLP] share price is $30.72. The Score for SLP is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SLP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IPHA Stock Price Chart

What is Innate Pharma SA's stock price today?

  • The Innate Pharma SA share price today is $2.08
    The current trend is moderately bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.

SLP Stock Price Chart

What is Simulations Plus's stock price today?

  • The Simulations Plus share price today is $30.72
    The current trend is moderately bearish and SLP is experiencing slight buying pressure.

IPHA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 47.62 Sell
Chaikin Money Flow: -16852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.91 - 2.27) Sell
Bollinger Bands (100): (1.81 - 2.17) Buy

SLP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.18 Buy
Relative Strength Index (14 RSI): 48.2 Sell
Chaikin Money Flow: 147811 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.49 - 35.13) Sell
Bollinger Bands (100): (26.5 - 34.14) Buy

IPHA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.27 Sell
20-day SMA: 2.15 Sell
50-day SMA: 2.02 Buy
200-day SMA: 2 Buy
8-day EMA: 2.21 Sell
20-day EMA: 2.16 Sell
50-day EMA: 2.06 Buy
200-day EMA: 2.07 Buy

SLP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.57 Buy
20-day SMA: 32.84 Sell
50-day SMA: 28.98 Buy
200-day SMA: 31.65 Sell
8-day EMA: 31.05 Sell
20-day EMA: 31.35 Sell
50-day EMA: 30.61 Buy
200-day EMA: 32.61 Sell

Innate Pharma SA Earnings Growth & IPHA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Simulations Plus Earnings Growth & SLP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.11 per share, an increase this year of $0.56 per share, and an increase next year of $0.14 per share.

Innate Pharma SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Simulations Plus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):